PrecisCa Oncology Podcast : Precision Cancer Insights

On this episode, PrecisCa speaks with Dr. Sara Hurvitz, medical oncologist & the Director of Breast Oncology at the David Geffen School of Medicine at UCLA. Dr. Hurvitz answers the following: Sara A Hurvitz, MD, is Professor of Medicine at the University of California, Los Angeles (UCLA); co-director of the Santa Monica-UCLA Outpatient Oncology Practice; Medical Director of the Clinical Research Unit of the Jonsson Comprehensive Cancer Center at UCLA; and Director of Breast Oncology. Dr. Hurvitz received board-certification in internal medicine, hematology, and medical oncology. Dr. Hurvitz has won numerous awards over the past few years, among them the Marni Levine Memorial Breast Cancer Research Award 2008 through 2015. Visit www.precisca.com for more resources, content, and access to our entire catalogue of educational content. There you will have access to our complete library of educational videos. New episodes of the PrecisCa Oncology Podcast are released weekly. Please consider sharing our podcast, subscribing & turning on notifications to be the first to know about new releases. Together, we can raise the level of cancer care from diagnosis to recovery.

On this episode, PrecisCa speaks with Dr. Michael Lanuti, an Associate Professor of Surgery at Harvard Medical School & the Director of Thoracic Oncology, Division of Thoracic Surgery at Massachusetts General Hospital. Dr. Lanuti sits down with PrecisCa to discuss the following: Dr. Lanuti is the Director of Thoracic Oncology for the Division of Thoracic Surgery and the Thoracic Surgery liaison to the MGH Cancer Center. Clinical interests include minimally invasive surgery for lung cancer, complex airway tumors, multimodality treatment of esophageal cancer, mediastinal tumors, navigation and robotic bronchoscopy, non surgical treatment of lung tumors using percutaneous and bronchoscope thermal ablation techniques. Dr. Lanuti spearheads translational research in a Thoracic Oncology Research Laboratory. The principle goals of the laboratory are to design novel therapeutics to treat lung and esophageal cancer that can be brought to clinical trials. The laboratory uses oncolytic viruses in combination with other modalities such as chemotherapy and angiotensin system inhibitors to target solid tumor. Some of these strategies include development of oncolytic viruses that help degrade tumor matrix. Ultimately, this translational effort will strive to bring treatment strategies from the laboratory bench to the bedside and back to the bench again for re-evaluation and improvement. Dr. Lanuti has investigated molecular risk factors for esophageal adenocarcinoma and found an elevated risk associated with single nucleotide polymorphisms in the epidermal growth factor (EGF) gene which is associated with differentiation of tumor tissue After receiving a Bachelor of Science in Bioengineering from the University of Pennsylvania, Dr. Lanuti received his M.D. degree from the University of Pennsylvania School of Medicine. He completed his internship and residency in Surgery at the Hospital of the University of Pennsylvania and a 2-year research fellowship in a Thoracic Oncology Laboratory focusing on novel treatments for lung cancer. Dr. Lanuti continued with sub-specialty training and completed a Cardiothoracic Fellowship at the Massachusetts General Hospital. He has been on staff in the Division of Thoracic Surgery since 2004 and holds a parallel appointment as Associate Professor of Surgery at Harvard Medical School. He has been the Friedman-Lambert Scholar in Academic Thoracic Surgery at MGH/HMS since 2004 and directs a Thoracic Oncology Research Lab for the past 15 years focusing on novel treatment of lung cancer, pulmonary fibrosis and imaging of radiation induced lung injury in the setting of lung cancer. Visit www.precisca.com for more resources, content, and access to our entire catalogue of educational content. There you will have access to our complete library of educational videos. New episodes of the PrecisCa Oncology Podcast are released weekly. Please consider sharing our podcast, subscribing & turning on notifications to be the first to know about new releases. Together, we can raise the level of cancer care from diagnosis to recovery.

On this episode, PrecisCa speaks with Dr. Michael Lanuti, an Associate Professor of Surgery at Harvard Medical School & the Director of Thoracic Oncology, Division of Thoracic Surgery at Massachusetts General Hospital. Dr. Lanuti sits down with PrecisCa to discuss the following: Dr. Lanuti spearheads translational research in a Thoracic Oncology Research Laboratory. The principle goals of the laboratory are to design novel therapeutics to treat lung and esophageal cancer that can be brought...

On this episode, PrecisCa speaks with Dr. Joyce O'Shaughnessy, a medical oncologist and the Director of Breast Cancer Research Program at Baylor University Medical Center in Dallas, Texas. Dr. O'Shaughnessy sits down with us to answer the following questions: Joyce A. O’Shaughnessy, M.D. focuses on breast cancer prevention and treatment. She is Co-Chair of Breast Cancer Research and Chair of Breast Cancer Prevention Research at Baylor-Sammons Cancer Center and for The US Oncology Network and is a member of the Scientific Advisory Board for US Oncology Research Network. In 2009 D Magazine elected Dr. O’Shaughnessy as one of the best hematology oncologists in Dallas, Texas. Dr. O’Shaughnessy received her M.D. from Yale University Medical School. Her internship and residency in internal medicine were completed at Massachusetts General Hospital in 1985. She concluded a fellowship in medical oncology at the National Cancer Institute in 1987 and was a Senior Investigator there until 1995. Dr. O’Shaughnessy is a member of American Association for Cancer Research; American Society of Clinical Oncology; American Medical Women’s Association; American Medical Association; American College of Physicians; and Women in Cancer Research. Dr. O’Shaughnessy is an Associate Editor, Clinical Breast Cancer Journal; founder, The School of Breast Oncology. Visit www.precisca.com for more resources, content, and access to our entire catalogue of educational content.

On this episode, PrecisCa speaks with Dr. Suresh Ramalingam, medical oncologist and Executive Director at the Winship Cancer Institute of Emory University in Atlanta, Georgia. Dr. Ramalingam sits down with us to answer the following questions: Board certified in medical oncology, Suresh S. Ramalingam, MD, FACP, FASCO, is nationally recognized as an investigator and a physician in the area of small cell and non-small cell lung cancer. Dr. Ramalingam serves as executive director of Winship Cancer Institute of Emory University and associate vice president for cancer of Woodruff Health Sciences Center. He is past-president of the Georgia Society of Oncology and a member of the board of Georgia CORE. He is a Fellow of the American Society of Clinical Oncology and a Georgia Cancer Coalition Distinguished Cancer Scholar. Dr. Ramalingam holds professional memberships with American Society of Clinical Oncology, American Association for Cancer Research, and International Association of Lung Cancer Study. He plays an active role in the ECOG-ACRIN Cancer Research Group as the Chair of the Thoracic Malignancies Committee and as the Deputy Chair of Therapeutics Programs. He serves on several international, national and institutional committees. He is a member of the Medical Oncology Board Exam Committee for American Board of Internal Medicine. Visit www.precisca.com for more resources, content, and access to our entire catalogue of educational content. There you will have access to our complete library of educational videos. New episodes of the PrecisCa Oncology Podcast are released weekly. Please consider sharing our podcast, subscribing & turning on notifications to be the first to know about new releases. Together, we can raise the level of cancer care from diagnosis to recovery.

On this episode, PrecisCa speaks with Yi-Bin Chen MD, MS. Dr. Chen is the Director of the Transplant and Cell Therapy program at Massachusetts General Hospital/Harvard Medical School -- uniting the programs of conventional transplant and emerging cellular therapies. His clinical interests mainly revolve around improving the outcomes of patients undergoing autologous and allogeneic stem cell transplantation. Dr. Chen sits down with us to answer the following questions: Yi-Bin Chen grew up in New Jersey. He majored in molecular biophysics and biochemistry, earning a B.S./M.S. at Yale University before attending medical school at Harvard Medical School. Subsequently, Dr. Chen did his internship and residency at Massachusetts General Hospital, including an additional year as Chief Resident. This was followed by a fellowship in hematology/oncology at the Dana-Farber Mass General Brigham combined program. In 2008, he joined the staff of the Blood & Marrow Transplant (BMT) Program at the MGH Cancer Center, has served as Director of Clinical Research since 2012 and was named overall Program Director in 2016. In 2020, he was named Director of the Hematopoietic Cell Transplant and Cell Therapy Program, uniting the programs of conventional transplant and emerging cellular therapies. His clinical interests mainly revolve around improving the outcomes of patients undergoing autologous and allogeneic stem cell transplantation. He has led original clinical trials involving all aspects of BMT, including conditioning regimens, alternative graft sources, novel approaches concerning the prevention and therapy of acute and chronic graft-vs-host disease (GVHD) and the use of maintenance therapies after BMT. He collaborates extensively with local and national colleagues as well as industry in addition to developing his own original clinical trials. He currently lives in Needham, MA with his wife and two children.

On this episode, PrecisCa speaks with David M. Schuster MD, FACR. Dr. Schuster is a Professor in the Department of Radiology and Imaging Sciences at Emory University School of Medicine. Dr. Schuster also serves as Director of the Division of Nuclear Medicine and Molecular Imaging, and is a Georgia Research Alliance Distinguished Scientist. Board certified in radiology and nuclear medicine, he specializes in molecular medicine and integrative imaging. Dr. Schuster sits down with us to explain PET Scans, false readings & the importance of selecting the right scanners for the right situation. Visit www.precisca.com for more resources, content, and access to our entire catalogue of educational content. There you will have access to our complete library of educational videos. New episodes of the PrecisCa Oncology Podcast are released weekly. Please consider sharing our podcast, subscribing & turning on notifications to be the first to know about new releases. Together, we can raise the level of cancer care from diagnosis to recovery.

Dr. Collins graduated from the University of Florida with a Bachelor of Science in Biology and again with her Master of Science in Human Nutrition. She started her career with the National Institute of Health Clinical Research Center in Charlottesville, VA. In 2007 she graduated from the University of Tennessee, Knoxville with her Ph.D. in Experimental Psychology after defending her research dissertation: “Hope, Coping Style, Quality of Life, Knowledge about Cancer and risks for Dietary Deficiency in Patients with Total Gastrectomy for Stomach Cancer.” She is also a registered dietitian with the Academy of Nutrition and Dietetics. She belongs to the Oncology DPG and Dietitians in Integrative and Functional Medicine (DIFM). Presentations include Dietary Intake, Coping Style and Quality of Life in Patients Undergoing Radiation Treatment(American Institute of Cancer Research) and Keep It Healthy –Be Fit and Flourish a Breast Cancer Survivorship Program (FNCE). Dr. Collins is on advisory boards for Keiser University and teaches a wide variety of classes on the college level in both psychology and nutrition fields. She is owner of CB7, LLC DBA Creation Balance and CSC. Visit www.precisca.com for more resources, content, and access to our entire catalogue of educational content. There you will have access to our complete library of educational videos. New episodes of the PrecisCa Oncology Podcast are released weekly. Please consider sharing our podcast, subscribing & turning on notifications to be the first to know about new releases. Together, we can raise the level of cancer care from diagnosis to recovery.

On this episode we hear from Thoracic Medical oncologist Dr. Thomas Stinchcombe. Dr. Stinchcombe is a member of Duke Cancer Institute, and Thoracic Oncology Program at Duke University in Durham, North Carolina. Dr. Stinchcombe explains whether or not they would recommend RET inhibitors as first line therapy for a RET-fusion positive metastatic Non-Small Cell Lung Cancer patient, what drugs are available to treat patients with Non-Small Lung Cancer and MET exon 14 skipping alterations, the significance of a metastatic Non-Small Cell Lung Cancer patient with a ERBB2 or HER2 alteration & whether there are specific mutations that are targetable for HER2. We conclude with a breakdown of the role of immune check point inhibitors in patients with resected Non-Small Cell Lung Cancer & the role of adjuvant therapy with atezolizumab. Visit www.precisca.com for more resources, content, and access to our entire catalogue of educational content. There you will have access to our complete library of educational videos. New episodes of the PrecisCa Oncology Podcast are released weekly. Please consider sharing our podcast, subscribing & turning on notifications to be the first to know about new releases. Together, we can raise the level of cancer care from diagnosis to recovery.

On this episode we hear from Dr. Monica Morrow. Dr. Morrow is Anne Burnett Windfohr Chair of Clinical Oncology, Professor of Surgery at Memorial Sloan Kettering Cancer Center in New York City. Dr. Morrow is a surgical oncologist with a practice dedicated to the treatment of breast cancer. Dr. Morrow's research has focused on how to apply the advances from clinical trials to daily surgical practice. Her research interests include how treatment choices for breast cancer surgery are made and identifying factors which predict for successful lumpectomy. Visit www.precisca.com for more resources, content, and access to our entire catalogue of educational content. There you will have access to our complete library of educational videos. New episodes of the PrecisCa Oncology Podcast are released weekly. Please consider sharing our podcast, subscribing & turning on notifications to be the first to know about new releases. Together, we can raise the level of cancer care from diagnosis to recovery.

On this episode we hear from Dr. Steven Poplack from Stanford University. Dr. Poplack explains the various types of breast biopsies, the difference between screening and diagnostic imaging & how often breast cancer survivors should undergo breast cancer screening. Visit www.precisca.com for more resources, content, and access to our entire catalogue of educational content. There you will have access to our complete library of educational videos. New episodes of the PrecisCa Oncology Podcast are released weekly. Please consider sharing our podcast, subscribing & turning on notifications to be the first to know about new releases. Together, we can raise the level of cancer care from diagnosis to recovery.

PrecisCa sits down with Dr. Tari King and Dr. Monica Morrow as they answer select questions about breast surgery. Visit www.precisca.com for more resources, content, and access to our entire catalogue of educational content. There you will have access to our complete library of educational videos. New episodes of the PrecisCa Oncology Podcast are released weekly. Please consider sharing our podcast, subscribing & turning on notifications to be the first to know about new releases. Together, we can raise the level of cancer care from diagnosis to recovery.

Drs. Terry Mamounas & Mark Pegram discuss exciting new developments from the 2021 San Antonio Breast Cancer Symposium. See our Abstract outlining the value of virtual tumor boards presented at SABCS21 HERE Visit www.precisca.com for more resources, content, and access to our entire catalogue of educational content. There you will have access to our complete library of educational videos. New episodes of the PrecisCa Oncology Podcast are released weekly. Please consider sharing our podcast, subscribing & turning on notifications to be the first to know about new releases. Together, we can raise the level of cancer care from diagnosis to recovery.

Drs. Joyce O'Shaughnessy & Ann O'Dea discuss exciting new developments from the 2021 San Antonio Breast Cancer Symposium. See our Abstract outlining the value of virtual tumor boards presented at SABCS21 HERE Visit www.precisca.com for more resources, content, and access to our entire catalogue of educational content. There you will have access to our complete library of educational videos. New episodes of the PrecisCa Oncology Podcast are released weekly. Please consider sharing our podcast, subscribing & turning on notifications to be the first to know about new releases. Together, we can raise the level of cancer care from diagnosis to recovery.

PrecisCa sits down with Dr. Frank Vicini, a Clinical Professor of Breast Radiation Oncology with Genesis Care, in Farmington Hills, Pontiac, & Troy, MI Visit www.precisca.com for more resources, content, and access to our entire catalogue of educational content. There you will have access to our complete library of educational videos. New episodes of the PrecisCa Oncology Podcast are released weekly. Please consider sharing our podcast, subscribing & turning on notifications to be the first to know about new releases. Together, we can raise the level of cancer care from diagnosis to recovery.

PrecisCa sits down with Dr. Cliff Robinson to answer patients questions about undergoing radiation therapy, and Dr. Cindy Collins discusses dealing with anxiety and depression during treatment. Visit www.precisca.com for more resources, content, and access to our entire catalogue of educational content. There you will have access to our complete library of educational videos. New episodes of the PrecisCa Oncology Podcast are released weekly. Please consider sharing our podcast, subscribing & turning on notifications to be the first to know about new releases. Together, we can raise the level of cancer care from diagnosis to recovery.

PrecisCa sits down with faculty members Dr. Ross Camidge, Dr. Benjamin Levy, Dr. Cliff Robinson, Dr. Jack West, & Dr. Thomas Stinchcombe as they share stories of exceptional responders with lung cancer. Visit www.precisca.com for more resources, content, and access to our entire catalogue of educational content. There you will have access to our complete library of educational videos. New episodes of the PrecisCa Oncology Podcast are released weekly. Please consider sharing our podcast, subscribing & turning on notifications to be the first to know about new releases. Together, we can raise the level of cancer care from diagnosis to recovery.

On today’s program we hear from 5 gastrointestinal oncologists - Doctors Christopher Lieu, Samuel Klempner, Michael Pishvaian, Daniel Catenacci, & Al Benson. These PrecisCa faculty members share stories of GI cancer patients that responded well to novel treatments, clinical trials, or emerging research. Visit www.precisca.com for more resources, content, and access to our entire catalogue of educational content. There you will have access to our complete library of educational videos. New episodes of the PrecisCa Oncology Podcast are released weekly. Please consider sharing our podcast, subscribing & turning on notifications to be the first to know about new releases. Together, we can raise the level of cancer care from diagnosis to recovery. contact: podcast@precisca.com

PrecisCa sits down with faculty members Sara Hurvitz MD , William Gradishar MD, Joyce O’Shaughnessy MD & Mark Pegram MD, to share stories of cancer patients that responded well to novel treatments, clinical trials, or their research. Visit www.precisca.com for more resources, content, and access to our entire catalogue of educational content. There you will have access to our complete library of educational videos. New episodes of the PrecisCa Oncology Podcast are released weekly. Please consider sharing our podcast, subscribing & turning on notifications to be the first to know about new releases. Together, we can raise the level of cancer care from diagnosis to recovery. contact: podcast@precisca.com